CJC-1295 DAC is dosed at 1 mg–2 mg weekly via subcutaneous injection in educational protocols. A 5 mg reconstituted with bacteriostatic water yields about 2.5 mg/mL. This information is for research and educational use only.
Educational guide for stacked GH secretagogue protocol
Reconstitution: 2.0 mL bacteriostatic water → 2.5 mg/mL (2500 mcg/mL) → 25 mcg per unit
| Phase | Weekly Dose (mcg / mg) | Units (mL) per Injection | Frequency |
|---|---|---|---|
| Standard | 1000 mcg (1.0 mg) | 40 units (0.40 mL) | Once weekly |
| Aggressive | 2000 mcg (2.0 mg) | 80 units (0.80 mL) | Once weekly |
Note: At 2.5 mg/mL, each 5 mg vial provides 2.5 standard doses (1 mg each) or 1.25 aggressive doses (2 mg each).
Reconstitution: 3.0 mL bacteriostatic water → 1.67 mg/mL (1666.7 mcg/mL) → 16.67 mcg per unit
| Phase | Daily Dose (mcg / mg) | Units (mL) per Injection | Frequency |
|---|---|---|---|
| Weeks 1–2 (Initiation) | 100 mcg (0.1 mg) | 6 units (0.06 mL) | Once daily |
| Weeks 3–4 (Titration) | 150 mcg (0.15 mg) | 9 units (0.09 mL) | Once daily |
| Weeks 5+ (Maintenance) | 200 mcg (0.2 mg) | 12 units (0.12 mL) | Once daily |
| Aggressive (Optional) | 300 mcg (0.3 mg) | 18 units (0.18 mL) | Once daily or split 2×/day |
For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
| Week | CJC-1295 DAC (Weekly) | Ipamorelin (Daily) |
|---|---|---|
| Weeks 1–2 | 1000 mcg (40 units) once weekly | 100 mcg (6 units) once daily |
| Weeks 3–4 | 1000 mcg (40 units) once weekly | 150 mcg (9 units) once daily |
| Weeks 5–12 | 1000 mcg (40 units) once weekly | 200 mcg (12 units) once daily |
For Ipamorelin doses ≤10 units, 30- or 50-unit syringes improve accuracy.
General product information provided for educational and research reference only.
Proper storage information is provided for <b>general educational and research reference only</b>.
Practical product information for general educational and research reference only.
CJC-1295 DAC and Ipamorelin information is provided for <b>general educational and research reference only</b>. This section is intended to give visitors a simple overview of the product category without providing medical advice, treatment guidance, dosage guidance, or usage instruction. For <b>product-specific details</b>, <b>availability</b>, or additional information, please contact us on Telegram.
Complementary strategies for optimal outcomes.
General product handling information for educational and research reference only.
Explore related research dosage protocols and background reading for BPC-157 + TB-500.
Explore related research dosage protocols and background reading for BPC-157 + TB-500.